ARCHIVES

EntreMed Begins Phase I/II Trial For Endostatin.

This article is from The Cancer Letter archive.

Vol. 27 No. 30 | July 27, 2001

Download PDF Visit The Full Archive

Related Articles

Space Station Attacked By Health Research Advocates on Earth

May 8, 1992

Conferess Ok $10.9 Bil. NIH Bidget, OAM to Get $3.5 Million

October 15, 1993

FDA Didn’t Punish Duke for Failing To Seek Proper Regulatory Clearance for Three Trials

January 27, 2012

Half Of Women Complete Full Hormone Therapy Regimen

July 30, 2010

NCI Cuts Back Directed Research Funds, Encourages Investigator – Initiated Grants

February 23, 1996

NIH to ban consulting by top officials, limit outside work by other employees.

June 25, 2004